Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 2506 AL 2520

Can a targeted home-based exercise programme improve turning characteristics in individuals with Parkinson's disease?

Khobkhun F, Srivanitchapoom P, Richards J.

Clin Biomech (Bristol). 2021 Oct;89:105469. doi: 10.1016/j.clinbiomech.2021.105469. Epub 2021 Aug 27.

General Anesthesia vs Local Anesthesia in Microelectrode Recording-Guided Deep-Brain Stimulation for Parkinson Disease: The GALAXY Randomized Clinical Trial

Holewijn RA, Verbaan D, van den Munckhof PM, Bot M, Geurtsen GJ, Dijk JM, Odekerken VJ, Beudel M, de Bie RMA, Schuurman PR.

JAMA Neurol. 2021 Oct 1;78(10):1212-1219. doi: 10.1001/jamaneurol.2021.2979.

A Parkinson's disease patient displaying increased neuromelanin-sensitive areas in the substantia nigra after rehabilitation with tDCS: a case report

Ishikuro K, Hattori N, Imanishi R, Furuya K, Nakata T, Dougu N, Yamamoto M, Konishi H, Nukui T, Hayashi T, Anada R, Matsuda N, Hirosawa H, Tanaka R, Shibata T, Mori K, Noguchi K, Kuroda S, Nakatsuji Y, Nishijo H.

Neurocase. 2021 Oct;27(5):407-414. doi: 10.1080/13554794.2021.1975768. Epub 2021 Sep 10.

Transcranial Magnetic Stimulation in Tremor Syndromes: Pathophysiologic Insights and Therapeutic Role

Frey J, Hess CW, Kugler L, Wajid M, Wagle Shukla A.

Front Neurol. 2021 Aug 26;12:700026. doi: 10.3389/fneur.2021.700026. eCollection 2021.

Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial

Parkinson Study Group SURE-PD3 Investigators; Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB Jr, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, et al.

JAMA. 2021 Sep 14;326(10):926-939. doi: 10.1001/jama.2021.10207.

Coding and Noncoding Variation in LRRK2 and Parkinson's Disease Risk

Lake J, Reed X, Langston RG, Nalls MA, Gan-Or Z, Cookson MR, Singleton AB, Blauwendraat C, Leonard HL; International Parkinson's Disease Genomics Consortium (IPDGC).

Mov Disord. 2022 Jan;37(1):95-105. doi: 10.1002/mds.28787. Epub 2021 Sep 20.

Determinants of self-efficacy in patients with Parkinson's disease

Estrada-Bellmann I, Meléndez-Flores JD, Cámara-Lemarroy CR, Castillo-Torres SA.

Arq Neuropsiquiatr. 2021 Aug;79(8):686-691. doi: 10.1590/0004-282X-ANP-2020-0185.

Mild Parkinsonian Signs: A Systematic Review of Clinical, Imaging, and Pathological Associations

Buchanan SM, Richards M, Schott JM, Schrag A.

Mov Disord. 2021 Nov;36(11):2481-2493. doi: 10.1002/mds.28777. Epub 2021 Sep 25.

Repairing the Parkinson Brain

Björklund A, Bloem BR, Brundin P, Federoff H.

J Parkinsons Dis. 2021;11(s2):S123-S125. doi: 10.3233/JPD-219901.

Influence of istradefylline on non-motor symptoms of Parkinson's disease: A subanalysis of a 1-year observational study in Japan (J-FIRST)

Shimo Y, Maeda T, Chiu SW, Yamaguchi T, Kashihara K, Tsuboi Y, Nomoto M, Hattori N, Watanabe H, Saiki H; J-FIRST Group.

Parkinsonism Relat Disord. 2021 Oct;91:115-120. doi: 10.1016/j.parkreldis.2021.09.015. Epub 2021 Sep 21.

Drooling rating scales in Parkinson's disease: A systematic review

Nascimento D, Carmona J, Mestre T, Ferreira JJ, Guimarães I.

Parkinsonism Relat Disord. 2021 Oct;91:173-180. doi: 10.1016/j.parkreldis.2021.09.012. Epub 2021 Sep 21.

An atypical case of corticobasal syndrome with psychotic depression and delusional jealousy

Sönmez Güngör E, Durmaz O, Halilbeyoğlu B, Domaç SF.

Neurocase. 2021 Oct;27(5):425-429. doi: 10.1080/13554794.2021.1984539. Epub 2021 Sep 30.

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [(11) C]PBR28 and Machine Learning Analysis

Jucaite A, Cselényi Z, Kreisl WC, Rabiner EA, Varrone A, Carson RE, Rinne JO, Savage A, Schou M, Johnström P, Svenningsson P, Rascol O, Meissner WG, Barone P, Seppi K, Kaufmann H, Wenning GK, Poewe W, Farde L.

Mov Disord. 2022 Jan;37(1):119-129. doi: 10.1002/mds.28814. Epub 2021 Oct 5.

Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase Activity

Ysselstein D, Young TJ, Nguyen M, Padmanabhan S, Hirst WD, Dzamko N, Krainc D.

Mov Disord. 2021 Dec;36(12):2719-2730. doi: 10.1002/mds.28815. Epub 2021 Oct 6.

Functional neurological disorder and somatic symptom disorder in Parkinson's disease

Onofrj M, Russo M, Carrarini C, Delli Pizzi S, Thomas A, Bonanni L, Espay AJ, Sensi SL.

J Neurol Sci. 2022 Feb 15;433:120017. doi: 10.1016/j.jns.2021.120017. Epub 2021 Oct 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias